Pier Giorgio Natali

Pier Giorgio Natali's AcademicInfluence.com Rankings

Pier Giorgio Natali

Computer Science

#8283

World Rank

#8708

Historical Rank

Computational Linguistics

#1813

World Rank

#1832

Historical Rank

Machine Learning

#3353

World Rank

#3393

Historical Rank

Artificial Intelligence

#3651

World Rank

#3703

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Pier Giorgio Natali's Degrees

PhD Computer Science University of Milan
Masters Computer Science University of Milan
Bachelors Computer Science University of Milan

Similar Degrees You Can Earn

Why Is Pier Giorgio Natali Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Pier Giorgio Natali's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential (2000) (452)
A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors (1989) (335)
The receptor encoded by the human C‐MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors (1991) (313)
Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. (1990) (296)
Distribution and molecular characterization of a cell‐surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies (1981) (291)
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels (2003) (253)
The α3β1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (mmp‐9) activity (2000) (251)
Expression of the p185 encoded by her2 oncogene in normal and transformed human tissues (1990) (248)
Morphological, immunochemical, and biochemical study of rabbit achilles tendon at various ages. (1980) (231)
Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. (1999) (229)
Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. (1992) (215)
Low frequency of alterations of the α (PPP2R1A) and β (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms (2000) (205)
Endothelin-1 Induces Vascular Endothelial Growth Factor by Increasing Hypoxia-inducible Factor-1α in Ovarian Carcinoma Cells* (2002) (205)
Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. (1993) (203)
Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. (1996) (201)
α6β4 and α6β1 Integrins Associate with ErbB-2 in Human Carcinoma Cell Lines (1997) (200)
Role of endothelin-1 in neovascularization of ovarian carcinoma. (2000) (198)
The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells (2002) (194)
Endoglin: An accessory component of the TGF‐β‐binding receptor‐complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies (2001) (185)
Distribution of human Class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. (1984) (176)
Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells (2011) (174)
Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. (2005) (171)
Expression of class I and class II major histocompatibility complex antigens on human hepatocytes (1988) (169)
Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. (1986) (167)
Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. (2001) (165)
Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. (1999) (161)
Clinical Significance of αvβ3 Integrin and Intercellular Adhesion Molecule-1 Expression in Cutaneous Malignant Melanoma Lesions (1997) (160)
The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. (2000) (160)
Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. (2000) (153)
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. (2002) (150)
β-Arrestin links endothelin A receptor to β-catenin signaling to induce ovarian cancer cell invasion and metastasis (2009) (150)
Overexpression of the met/HGF receptor in renal cell carcinomas (1996) (147)
Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues (1991) (147)
Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions. (1983) (146)
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. (2000) (136)
Endothelin B Receptor Blockade Inhibits Dynamics of Cell Interactions and Communications in Melanoma Cell Progression (2004) (132)
Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. (1983) (127)
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. (2000) (117)
Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma. (2003) (115)
Prognostic relevance of altered Fas (CD95)‐system in human breast cancer (2000) (114)
Endothelin receptors as novel targets in tumor therapy (2004) (114)
Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells. (1981) (112)
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study (2008) (110)
A 94,000-dalton glycoprotein expressed by human melanoma and carcinoma cells. (1982) (106)
Endothelin-1-induced Prostaglandin E2-EP2, EP4 Signaling Regulates Vascular Endothelial Growth Factor Production and Ovarian Carcinoma Cell Invasion* (2004) (104)
Chemotherapy enhances vaccine‐induced antitumor immunity in melanoma patients (2009) (102)
CXCR6, a Newly Defined Biomarker of Tissue-Specific Stem Cell Asymmetric Self-Renewal, Identifies More Aggressive Human Melanoma Cancer Stem Cells (2010) (100)
Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non‐lymphoid human tissues (2008) (96)
The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors (2006) (95)
Human mena protein, a serex‐defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T‐cell immune response (2004) (95)
Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy (2015) (92)
Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy. (2014) (91)
c‐Kit is preferentially expressed in MYCN‐amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI‐571 (2003) (91)
Experimental skin lesions in mice resembling systemic lupus erythematosus. (1973) (89)
Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. (1995) (89)
Endothelin-1 Decreases Gap Junctional Intercellular Communication by Inducing Phosphorylation of Connexin 43 in Human Ovarian Carcinoma Cells* (2003) (88)
Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines. (2007) (88)
Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade. (2009) (86)
Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade. (2002) (84)
Expression of the mage gene family in primary and metastatic human breast cancer: Implications for tumor antigen‐specific immunotherapy (1995) (83)
Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. (1997) (82)
Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma. (1984) (82)
Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma (2006) (81)
Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma (2006) (80)
Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens. (1984) (80)
Transformation of thyroid epithelium is associated with loss of c-kit receptor. (1995) (79)
Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines. (1997) (79)
β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling (2013) (79)
Tissue distribution, molecular profile, and shedding of a cytoplasmic antigen identified by the monoclonal antibody 465.12S to human melanoma cells. (1982) (76)
Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells (2007) (76)
Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions (2006) (76)
Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I‐labelled anti‐tenascin monoclonal antibody BC‐2 (1992) (75)
Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells (2010) (70)
Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells. (2011) (70)
Human Mena+11a Isoform Serves as a Marker of Epithelial Phenotype and Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Pancreatic Cancer Cell Lines (2008) (69)
Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase. (1995) (69)
Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity. (2007) (69)
Inhibition of Cyclooxygenase-1 and -2 Expression by Targeting the Endothelin A Receptor in Human Ovarian Carcinoma Cells (2004) (68)
Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin. (1996) (66)
Ferritin Contributes to Melanoma Progression by Modulating Cell Growth and Sensitivity to Oxidative Stress (2005) (66)
Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma. (1996) (64)
Analysis of APAF‐1 expression in human cutaneous melanoma progression (2004) (63)
Cancer testis antigens in human melanoma stem cells: Expression, distribution, and methylation status (2008) (63)
Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma. (1985) (61)
ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo (2007) (60)
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer (2016) (60)
Expression of VE (vascular endothelial)‐cadherin and other endothelial‐specific markers in haemangiomas (1995) (59)
High homogeneity of MAGE, BAGE, GAGE, Tyrosinase and Melan‐A/MART‐1 gene expression in clusters of multiple simultaneous metastases of human melanoma: Implications for protocol design of therapeutic antigen‐specific vaccination strategies (1998) (59)
The synergistic activity of thyroid transcription factor 1 and Pax 8 relies on the promoter/enhancer interplay. (2002) (59)
Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants. (1985) (57)
Experimental renal disease induced by DNA-anti-DNA immune complexes. (1972) (57)
Identification of genes down‐regulated during melanoma progression: a cDNA array study (2003) (57)
Monoclonal antibodies to glutathione S‐Transferase π–immunohistochemical analysis of human tissues and cancers (1991) (56)
Regulation of class II MHC gene expression by interferons: insights into the mechanism of action of interferon (review). (1988) (56)
Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells (2013) (56)
Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells. (1996) (54)
Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment. (2000) (54)
Expression and production of tenascin in benign and malignant lesions of melanocyte lineage (1990) (54)
Comparative study of antibodies to native and denatured DNA. (1970) (54)
NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells. (2010) (54)
Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo. (2003) (54)
Double determinant immunoassay to measure a human high-molecular-weight melanoma-associated antigen. (1983) (53)
Expression of AP‐2 transcription factor and of its downstream target genes c‐kit, E‐cadherin and p21 in human cutaneous melanoma (2001) (52)
Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin. (1986) (52)
Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients. (2010) (51)
Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: Immunotherapeutic implications (2006) (51)
Expression of the c‐Kit receptor and its ligand SCF in non‐small‐cell lung carcinomas (1998) (51)
Endothelin-1 Inhibits Prolyl Hydroxylase Domain 2 to Activate Hypoxia-Inducible Factor-1α in Melanoma Cells (2010) (51)
Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models (2015) (51)
From the fetal liver to spleen and gut: the highway to natural antibody (2009) (50)
Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells. (2007) (49)
Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. (1995) (48)
Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression. (1993) (47)
Tumor progression in human malignant melanoma is associated with changes in α6/β1 laminin receptor (1991) (47)
CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage (2003) (46)
Antigenic heterogeneity of skin tumors of nonmelanocyte origin: analysis with monoclonal antibodies to tumor-associated antigens and to histocompatibility antigens. (1983) (46)
Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies. (1989) (45)
The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor. (2014) (43)
Immunological detection of thymidine photoproduct formation in vivo. (1971) (42)
Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based Chemotherapy (2004) (41)
Expression of HL-A antigens in synchronized cultures of human lymphocytes. (1972) (41)
Production and characterization of the murine monoclonal antibody 2G10 to a human T4-tyrosinase epitope. (1991) (41)
Tenascin: A hexameric adhesive glycoprotein (1989) (41)
Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products. (1999) (40)
Cell-to-Cell Signaling Influences the Fate of Prostate Cancer Stem Cells and Their Potential to Generate More Aggressive Tumors (2012) (40)
Transformation and tumor progression are frequently associated with expression of the α3/β1 heterodimer in solid tumors (1994) (40)
Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells. (2001) (40)
Endothelin-1 promotes proteolytic activity of ovarian carcinoma. (2002) (40)
Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1‐T2, N0 breast cancer patients undergoing adjuvant chemotherapy (2013) (40)
Endothelin-1 Is Required During Epithelial to Mesenchymal Transition in Ovarian Cancer Progression (2006) (39)
Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells. (1990) (39)
Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors. (2005) (39)
Heat‐shock proteins produced by two human melanoma cell lines: Absence of correlation with thermosensitivity (1984) (38)
Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen. (1987) (38)
Melanoma molecular classes and prognosis in the postgenomic era. (2012) (38)
Ia-like antigens on freshly explanted human melanoma. (1981) (38)
Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients (2009) (37)
Recombinant human IFN-gamma, but not IFN-alpha or IFN-beta, enhances MHC- and non-MHC-encoded glycoproteins by a protein synthesis-dependent mechanism. (1988) (37)
Expression of α3β1 integrin receptor and its ligands in human lung tumors (1995) (37)
Production and characterization of murine mAbs to the extracellular domain of human neu oncogene product GP185HER2. (1992) (37)
Expression of Ia-like antigens on the vasculature of human kidney. (1981) (37)
Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies. (1985) (36)
Quercetin and tamoxifen sensitize human melanoma cells to hyperthermia (2001) (35)
Functional expression of a single-chain antibody to ErbB-2 in plants and cell-free systems (2006) (35)
LMNA Knock-Down Affects Differentiation and Progression of Human Neuroblastoma Cells (2012) (35)
Retinoblastoma protein acts as Pax 8 transcriptional coactivator (2005) (34)
Evaluation of MicroRNA expression pattern of gastric adenocarcinoma associated with socioeconomic, environmental and lifestyle factors in northwestern Hungary. (2013) (33)
Expression of gp 185HER‐2 in human cutaneous melanoma: Implications for experimental immunotherapeutics (1994) (33)
Analysis of the Expression of I‐Ak‐like Antigens in Murine Fetal and Adult Tissues with the Monoclonal Antibody 10–2.16 (1981) (33)
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling (2012) (33)
99mTc-MIBI scintimammography using a dedicated nuclear mammograph. (1999) (33)
Localization of ahe alpha 6 and beta 4 integrin subunits in normal human non-lymphoid tissues. (1992) (32)
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer (2014) (32)
Antitumor Effect of Green Tea Polyphenol Epigallocatechin-3-Gallate in Ovarian Carcinoma Cells: Evidence for the Endothelin-1 as a Potential Target (2006) (32)
Skin cancer risk factors among primary school children: investigations in Western Hungary. (2010) (31)
Understanding Human Cancer Using Drosophila (2003) (30)
Rapid perinatal growth mimicking malignant transformation in a giant congenital melanocytic nevus. (1991) (30)
Ultrastructural and immunochemical evidence of actin in the tendon cells. (1977) (29)
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process (2014) (28)
Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells. (1997) (28)
Modulation of the antigenic phenotype of early‐passage human melanoma cells derived from multiple autologous metastases by recombinant human leukocyte, fibroblast and immune interferon (1990) (27)
Antitumor Efficacy of bcl-2 and c-myc Antisense Oligonucleotides in Combination with Cisplatin in Human Melanoma Xenografts: Relevance of the Administration Sequence (2005) (27)
Prognostic relevance of LGALS3BP in human colorectal carcinoma (2015) (26)
Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance (1987) (26)
ZD4054, a Potent Endothelin Receptor A Antagonist, Inhibits Ovarian Carcinoma Cell Proliferation (2006) (26)
cDNA‐array profiling of melanomas and paired melanocyte cultures (2006) (25)
β-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinaseThis article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research. (2010) (25)
Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor. (2008) (25)
CD40 Expression by Human Melanocytic Lesions and Melanoma Cell Lines and Direct CD40 Targeting With the Therapeutic Anti-CD40 Antibody CP-870,893 (2010) (25)
Topographic association of fibronectin with elastic fibers in the arterial wall. An immunohistochemical study. (1981) (25)
Multiple epitope recognition: An approach to improved radioimmunodetection of tumor‐associated antigens (1987) (24)
Antibody-coated protein A-bearing Staphylococcus aureus: a versatile and stable immune reagent. (1979) (24)
Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies. (1990) (23)
Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancer (2005) (22)
Endothelin-1 Stimulates Cyclooxygenase-2 Expression in Ovarian Cancer Cells Through Multiple Signaling Pathways: Evidence for Involvement of Transactivation of the Epidermal Growth Factor Receptor (2004) (22)
Bispecific monoclonal antibody anti‐CD3 X anti‐tenascin: An immunotherapeutic agent for human glioma (1995) (22)
Tissue distribution of Ia-like antigens in different species: analysis with monoclonal antibodies. (1981) (22)
Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase. (2010) (22)
Targeting endothelin axis in cancer. (2004) (22)
ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro. (2002) (22)
Transformation and tumor progression are frequently associated with expression of the alpha 3/beta 1 heterodimer in solid tumors. (1994) (21)
Emerging role of protectin (CD59) in humoral immunotherapy of solid malignancies. (2000) (20)
Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DR alpha gene. (1991) (20)
Generation and characterization of the murine monoclonal antibody M-KID 2 to VLA-3 integrin. (1991) (20)
Expression and regulation of B7‐H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: Immunotherapeutic implications (2011) (20)
Idiotypic replica of an anti-human tumor-associated antigen monoclonal antibody. Analysis of monoclonal Ab1 and Ab3 fine specificity. (1989) (20)
Lack of correlation between hypomethylation and expression of the HLA‐DRα gene (1986) (20)
Endothelin axis induces metalloproteinase activation and invasiveness in human lymphatic endothelial cells. (2010) (20)
A melanoma immune response signature including Human Leukocyte Antigen‐E (2014) (20)
5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man story. (2007) (20)
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes (2019) (20)
Postnatal development of epididymis and ductus deferens in the rat (1987) (20)
Recombinant anti-human melanoma antibodies are versatile molecules. (1996) (19)
Melan-A/MART-1 antigen expression in cutaneous and ocular melanomas. (1997) (19)
Class I major histocompatibility complex enhancement by recombinant leukocyte interferon in the peripheral blood mononuclear cells and plasma of melanoma patients. (1991) (19)
Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma. (1992) (19)
HLA-C heavy chains free of beta2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsiveness. (1997) (19)
Isolation of soluble immune complexes from serum using protein A bearing Staphylococcus aureus bacteria: separation of the antigen from immune complex and production of antisera. (1980) (19)
Actin in the extracellular matrix of smooth muscle cells. An immunoelectron microscopic study. (1983) (19)
Distribution of a cross-species melanoma-associated antigen in normal and neoplastic human tissues. (1985) (18)
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma (2017) (18)
Vla-3 distribution in normal and neoplastic non-lymphoid human tissues. (1993) (17)
Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons. (1986) (16)
Immunochemical localization of contractile proteins in mammalian meiotic chromosomes (2004) (16)
Immunodiagnostic and immunotherapeutic applications of anti human melanoma associated antigen monoclonal antibodies. (1989) (16)
Ontogeny of human Ia antigens. (1982) (16)
Ultrastructural and immunohistochemical studies of rat epididymis (2004) (16)
Unknown primary tumors. (2011) (16)
Expression of HER-2/neu oncoprotein, DNA-ploidy and S-phase fraction in advanced ovarian cancer (1992) (16)
Precipitin reactions between polyribonucleotides and heat labile serum factors. (1972) (16)
Antigenic profile and functional characterization of human peritoneal macrophages. (1985) (16)
Regulation of the Expression of Class II Genes of the Human Major Histocompatibility Complex in Tumor Cells a (1987) (15)
Saporin 6 conjugated to monoclonal antibody selectively kills human melanoma cells (1991) (15)
Endothelin-B Receptor Blockade Inhibits Molecular Effectors of Melanoma Cell Progression (2004) (15)
Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens (2004) (14)
Spontaneous leptospiral infection of the rat kidney. An ultrastructural study. (1969) (14)
Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells. (1987) (14)
European multicentre study on melanoma immunoscintigraphy by means of 99mTc-labelled monoclonal antibody fragments. The European Multicentre Study Group. (1990) (14)
Therapeutic Targeting of the Endothelin-A Receptor in Human Ovarian Carcinoma: Efficacy of Cytotoxic Agents is Markedly Enhanced by Co-administration with Atrasentan (2004) (14)
Human glioblastoma ADF cells express tyrosinase, L‐tyrosine hydroxylase and melanosomes and are sensitive to L‐tyrosine and phenylthiourea (2006) (13)
Human HLA‐DRα gene: a rare oligonucleotide (GTATA) identifies an upstream sequence required for nuclear protein binding (1990) (13)
Combination therapy of zibotentan with cisplatinum and paclitaxel is an effective regimen for epithelial ovarian cancer. (2010) (13)
Effects of AF 1312/TS and lonidamine on cultured sertoli cells. (1981) (13)
Antitumor activity of the proteinase inhibitor tetra-p-amidinophenoxyneopentane in a nude mouse model of human melanoma. (1989) (13)
Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study (2020) (12)
"Self and parent-assessed skin cancer risk factors in school-age children". (2008) (12)
Ultrastructural Study of Mesangial Cells and Their Relationship to Smooth Muscle Cells of Glomerular Arterioles1 (1976) (12)
Tumor progression in human malignant melanoma is associated with changes in alpha 6/beta 1 laminin receptor. (1991) (12)
Lymphoid stroma of Warthin's tumor: phenotypic analogies with gut-associated lymphoid tissue. (1985) (12)
Human melanoma-associated antigens identified with monoclonal antibodies (1982) (12)
Hemopoietic progenitor cells in atopic dermatitis skin lesions. (1999) (12)
Changes in Ia-like antigen expression on malignant human cells (2005) (11)
Generation and characterization of two human alpha/beta T cell clones. Recognizing autologous breast tumor cells through an HLA- and TCR/CD3-independent pathway. (1994) (11)
Contractile filaments in cells of regenerating tendon (1977) (11)
Immunogenicity of soluble HL-A alloantigens. (1972) (11)
DNA methylation of the Ha-ras-1 oncogene in neoplastic cells. (1989) (11)
Expression of alpha 3 beta 1 integrin receptor and its ligands in human lung tumors. (1995) (11)
Prognostic value of HER2 and progesterone receptor expression in endometrial carcinoma with positive peritoneal washing. (2007) (11)
Laminin α2 Chain-Positive Vessels and Epidermal Growth Factor in Lung Neuroendocrine Carcinoma: A Model of a Novel Cooperative Role of Laminin-2 and Epidermal Growth Factor in Vessel Neoplastic Invasion and Metastasis (2006) (11)
Expression of tumor-associated antigens and kinetic profile of two in vitro human melanoma cell lines. (1981) (11)
Quantitation of estradiol receptors employing a sensitive radioimmunoassay. (1975) (11)
Distamycin analogues with improved sequence-specific DNA binding activities. (1994) (10)
Immunogenicity of DR antigens isolated from body fluids. (1980) (10)
Immunochemical Analysis of the Antigenic Profile of Human Melanoma Cells with Monoclonal Antibodies (1982) (10)
Study of proton spin‐lattice relaxation variation induced by paramagnetic antibodies (1989) (10)
Host immunosurveillance contributes to the control of erbB‐2 overexpression in HLA‐A2‐breast‐cancer patients (1999) (10)
Activation of T cells via tumor antigen specific chimeric receptors: The role of the intracellular signaling domain (2003) (9)
Immune complex formation in NZB/W mice after ultraviolet radiation. (1978) (9)
Inhibition of aerobic glycolysis in normal and neoplastic lymphoid cells induced by Lonidamine [1-(2,4-dichlorobenzyl)-I-H-indazol-3-carboxylic acid]. (1984) (9)
Sertoli cells of adult rats “in vitro” (1977) (9)
Effect of sequential application of hyperthermia and chemotherapy on the survival of a thermoresistant human melanoma cell line. (1987) (8)
First-trimester human trophoblast is class II major histocompatibility complex mRNA+/antigen. (1994) (8)
Differential expression of UN1, early thymocyte-associated sialoglycoprotein, in breast normal tissue, benign disease and carcinomas. (2002) (8)
Immunohistochemical detection of high-affinity nerve growth factor receptor in neuroblastoma. (1995) (8)
Combinations of monoclonal antibodies can distinguish primary lung tumors from metastatic lung tumors sampled by fine needle aspiration biopsy (1989) (8)
Monoclonal antibodies to a soluble metallic radioisotope chelator: development and characterization. (1991) (8)
Laminin alpha2 chain-positive vessels and epidermal growth factor in lung neuroendocrine carcinoma: a model of a novel cooperative role of laminin-2 and epidermal growth factor in vessel neoplastic invasion and metastasis. (2006) (8)
Tissue distribution and molecular profile of a differentiation antigen detected by a monoclonal antibody (345.134S) produced against human melanoma cells (1982) (8)
NF- κ B, and not MYCN, Regulates MHC Class I and Endoplasmic Reticulum Aminopeptidases in Human Neuroblastoma Cells (2010) (8)
Occurrence of globulin-like migrating blood albumins, or GLIMBAL, in pathological rat and human sera. (1980) (7)
Expression of Class II MHC Antigens in the Intestinal Epithelium of Pediatric Celiac Disease (1989) (7)
Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours (2006) (7)
Cytogenetic, molecular and phenotypic characterization of the newly established renal carcinoma cell line KJ29. Evidence of translocations for chromosomes 1 and 3. (1995) (7)
High frequency production of hybridomas secreting antibodies to cell antigens. (1987) (7)
Partial characterization of a fetal lung antigen associated with human bronchogenic carcinoma. (1979) (7)
Identification of the minimal melanocyte-specific promoter in the melanocortin receptor 1 gene (2008) (7)
Cell surface receptors and bispecific monoclonal antibodies: the link between basic science and medical oncology. (1993) (7)
Preparation, Characterization, and Utilization of Monoclonal Antibodies to the Gene Products of the HLA-D Region, with Special Emphasis on Those to Polymorphic Determinants (1986) (6)
Prognostic factors in Hungarian breast cancer patients. (2007) (6)
Influence of plastic embedding media on staining and morphology of lipid bodies (2004) (6)
Membrane compartmentalization of melanosomal gp75. (1992) (6)
In vivo evidence of htid suppressive activity on ErbB-2 in breast cancers over expressing the receptor (2010) (6)
An in vitro immuno-enzymatic assay of tumor antigens in the mouse with beta-galactosidase. (1976) (6)
CXCR 6 , a Newly Defined Biomarker of Tissue-Specific Stem Cell Asymmetric Self-Renewal , Identifies More Aggressive Human Melanoma Cancer Stem Cells (2010) (6)
Treatment with monoclonal antibody to a Lewis lung carcinoma-associated antigen: different effects on primary tumor and its metastases. (1985) (6)
Clinical improvement and partial correction of the T cell defects of acquired immunodeficiency syndrome (AIDS) and lymphoadenopathy syndrome (LAS) by a calf thymus acid lysate. (1986) (5)
Immunocytodiagnosis of atypical hyperplasia and endometrial carcinoma in post‐menopausal women (1992) (5)
Isolation of viable melanoma cells from surgically removed lesions using dishes coated with monoclonal antibody to a high molecular weight melanoma associated antigen. (1983) (5)
In vitro modulation of T-cell differentiation antigens on human thymocytes and splenocytes by a calf thymus acid lysate (1986) (5)
A cytoplasmic human melanoma associated antigen as a marker of activation in lymphoid cells. (1987) (5)
Expression of T-lineage early developmental markers by cells establishing atopic dermatitis skin infiltrates. (1998) (5)
Human Leukocyte Antigen E Contributes to Protect Tumor Cells from Lysis by Natural (2011) (5)
Two murine monoclonal antibodies to peripheral blood monocyte differentiation antigens discriminate within M5 acute non‐lymphoid leukemia (ANLL) cells (1987) (4)
Tissue-specific expression of theHLA-DRA gene in transgenic mice (2005) (4)
Immunohistochemical detection of p140trkA and p75LNGFR neurotrophin receptors in neuroblastoma (2004) (4)
Methylation pattern of the HLA-DR alpha gene in human tissues. (1990) (4)
[Skin cancer risk factors in childhood: findings of a survey conducted within Italian areas with a different incidence of melanoma]. (2011) (4)
A murine monoclonal antibody strictly reactive with human peripheral blood monocytes. (1987) (4)
Recombinant immune interferon down-regulates Ha-ras-1 proto-oncogene products in a human melanoma cell line. (1990) (4)
Mite antigens enhance ICAM-1 and induce VCAM-1 expression on human umbilical vein endothelium. (2003) (4)
Contents, Vol. 27, Suppl. 2, 1981 (1981) (4)
Lack of correlation between hypomethylation and expression of the HLA-DR alpha gene. (1986) (4)
Accessory cell function of human melanoma cells in mitogen-induced T cell proliferation. (1988) (4)
Soluble deoxyribonucleoprotein (sNP) complexes in the pleural effusion of rheumatoid arthritis. (1978) (4)
ZD 4054 , a specific antagonist of the endothelin A receptor , inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo (2007) (4)
SP-22 Analysis of APAF-1 Expression in Human Cutaneous Melanoma Progression (2003) (4)
Transgenic mice mimic the methylation pattern of the human HLA-DRα gene (1991) (4)
Immunotoxins to the HER-2 oncogene product: Functional and ultrastructural analysis of their cytotoxic activity (1994) (3)
Immunological and structural profile of a 96 kD human melanoma associated antigen with preferential distribution in metastases. (1988) (3)
Thy 1.2 inducing activity of a partially purified calf thymus acid lysate (1986) (3)
Malignant lentigo‐melanoma—A comparative histological and electron microscopy study (1981) (3)
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors (2021) (3)
Characterisation and protective capacity of monoclonal antibodies elicited in mice against protein epitopes of antibiotic-exposed Escherichia coli. (1997) (3)
Efficacy and Safety of Lycoprozen®, a Novel Tomato-Based Food Supplement in Patients with Benign Prostatic Hyperplasia (2018) (3)
Heterogeneous distribution of actin, myosin, fibronectin and basement membrane antigens in primary and metastatic human breast cancer (2004) (3)
Presence and role of contractile proteins in the vertebrate synaptonemal complex (1980) (3)
Sertoli cells of adult rats "in vitro". A morphologic and functional study. (1977) (3)
GENETIC ANALYSIS OF HUMAN T-CELL ANTIGENS. I. CYTOGENETIC AND PHENOTYPIC CHARACTERIZATION OF INTERSPECIES T-CELL LINES (1987) (3)
European multicentre study on melanoma immunoscintigraphy by means of99mTc-labelled monoclonal antibody fragments (2004) (3)
Monoclonal antibodies in cancer diagnosis. (1989) (3)
Tissue-specific expression of the HLA-DRA gene in transgenic mice (2004) (3)
Partial amino acid sequence of the V region of A κ-type Bence Jones cryoprotein (1978) (3)
Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections. (1994) (3)
Effect of complement and polymorphonuclear leukocyte depletion on experimental skin lesions resembling systemic lupus erythematosus. (1975) (3)
A Double Determinant Immunoassay (DDIA) with Monoclonal Antibodies to a Human High Molecular Weight Melanoma Associated Antigen (HMW-MAA) (1983) (3)
Spontaneous endometrial deposition of immune complexes in aging NZB/WF1 mice: possible role of oncornavirus antigens. (1980) (3)
Estimation of Fha Induced Transformation in Peripheral Blood Lymphocytes Through Measurement of their Increased Glycolysis. An Enzymatic Microusthod (1980) (3)
99mTc-MIBI breast scintigraphy using a dedicated nuclear mammograph (1998) (2)
Estimation of PHA induced transformation in peripheral blood lymphocytes through measurement of their increased glycolysis. An enzymatic micromethod. (1980) (2)
Protective features of monoclonal antibodies to Escherichia coli during experimental infection of mice with homologous and heterologous serotypes of E. coli. (2000) (2)
BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy. (1993) (2)
Ontogeny of murine I-Ak antigens in tissue of nonlymphoid origin (2004) (2)
Metastatic dissemination of 3LL variants after treatment with monoclonal antibody to a tumor-associated antigen (1987) (2)
Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific MAbs. (1990) (2)
Pharmacologic inhibition of experimentally induced SLE-like deposition of immunoglobulins in skin nuclei. (1983) (2)
The "Excellence in Translational Medicine" and "Bedside-to-Bench" Awards 2008-09 (2010) (2)
Immunoelectron microscopic evidence of contractile proteins in the cellular and acellular components of mouse kidney glomeruli (1975) (2)
Immunological and physiocochemical study of a crystallizable Bence-Jones cryoprotein. (1976) (2)
Human High Molecular Weight Melanoma-Associated Antigen: Immunochemical Profile and Clinical Applications (1987) (2)
Carbohydrate metabolism in PHA stimulated human peripheral blood lymphocytes. (1975) (2)
Levels of Ia-like antigen bearing lymphocytes in patients with solid primary tumors. (1981) (2)
Expression of glutathione transferase π in benign and malignant lesions of the melanocyte lineage (1992) (2)
Denaturing effect of x‐irradation on deoxyribonucleic acid aqueous solutions. An immunochemical study (1975) (2)
19TiPA phase Ib study combining the second-generation DNA hypomethylating agent (DHA) guadecitabine (SGI-110) and ipilimumab in patients with metastatic melanoma: The NIBIT-M4 Study (2015) (1)
Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies (2022) (1)
Thy 1.2 antigen inducing capacity of a calf thymus acid hydrolysate and its fractions. (1986) (1)
Differential effect of human and murine polyclonal and monoclonal antisera on TNF-alpha production by human monocytes. (1993) (1)
Differential denaturation of a crystalline Bence-Jones type cryoprotein as monitored by fluorescence. (1978) (1)
Methylation State of Cellular Genes and Oncogenes as a Marker of Malignancy in Human Carcinomas (1989) (1)
A C1q solid phase microenzymatic assay for the detection of soluble immune complexes (1981) (1)
Functional and prognostic significance of the genomic amplification of frizzled receptor 6 (FZD6) in breast cancer: FZD6 is frequently amplified in breast cancer (2017) (1)
CG Dinucleotides of class II MHC genes are mutation hot-spots (1988) (1)
Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study (2021) (1)
The "Excellence in Translational Medicine" and "Bedside-to-Bench" Awards 2007–08 (2009) (1)
Human Ia-like antigens (1981) (1)
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology (2018) (1)
GENETIC ANALYSIS OF HUMAN T-CELL ANTIGENS. II. MAPPING OF THE HUMAN CHROMOSOMES INVOLVED IN THE EXPRESSION OF T10 T-CELL ANTIGEN (1987) (1)
Mitogenic response of peripheral blood lymphocytes from lung cancer patients to a fetal lung antigen (1978) (0)
Abstract 493: Endothelin-1 induces activation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells (2012) (0)
[Anti-DNA antibodies]. (1976) (0)
Transgenic mice mimic the methylation pattern of the human HLA-DR alpha gene. (1991) (0)
Abstract 698: β-arrestin-1 as nuclear signalling element essential for endothelin A receptor-induced epithelial to mesenchymal transition and chemoresistance (2011) (0)
HumanMena + 11 a IsoformServes as aMarker of Epithelial Phenotype and Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Pancreatic Cancer Cell Lines (2008) (0)
Diversification of TCR repertoire in melanoma patients treated with chemotherapy before peptides-vaccination (41.19) (2009) (0)
Generation and Characterization of Two Human a/f8 T cell Clones Recognizing Autologous Breast Tumor Cells through an HLA- and TCR/CD3-lndependent Pathway (0)
Summary Localization of ahe 6 and 4 integrin subunits in normal human non-lymphoid tissues (0)
Immunohistochemical localization of contractile proteins, basement membrane, laminin, type IV collagen and fibronectin in the normal human breast and its disorders (1984) (0)
P118 – Cytofluorimetric analysis of HLA class I expression in non-linphoid neoplastic cells (1996) (0)
317 Activation of the endothelin signaling pathway is linked with acquisition epithelial–mesenchymal transition phenotype of chemoresistant ovarian cancer cells (2010) (0)
Abstract 3086: α-arrestin-1 acts as a nuclear transcriptional regulator of endothelin A receptor signalling to promote ovarian cancer progression (2012) (0)
350 Clinical and molecular features of neuroblastoma tumors that can be targeted through c-Kit (2004) (0)
Extracellular localization of actin in normal smooth muscle cells. Immunohistochemical studies (1984) (0)
Sertoli cells of adult rats in vitro. II. Effect of different steroid precursors on estradiol 17β-synthesis (1979) (0)
42. EXPRESSION OF CLASS II MHC ANTIGENS IN THE INTESTINAL EPITHELIUM OF PAEDIATRIC COELIAC DISEASE (CD) (1987) (0)
ALTERED EXPRESSION OF FAS SYSTEM IN OVARIAN CARCINOMAS: CORRELATION TO CONVENTIONAL PROGNOSTIC PARAMETERS (2003) (0)
arbazine Treatment before Peptide Vaccination rges T-Cell Repertoire Diversity of Melan-A–Specific, (2010) (0)
Production of xenoantiserum to a chemically induced murine tumor: analysis of tumor specificity in different immune tests. (1979) (0)
Endometrial deposition of immune complexes in aging nzb/wf1 mice. Possible role of oncornavirus antigens. Abstr. (1978) (0)
Abstract 3473: Endothelin axis autocrine loop is positively regulated by the interplay between ET-1 and hypoxia-inducible factor-1α in melanoma cells (2011) (0)
Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells (2012) (0)
Abstract 2363: Positive inter-regulation between β-catenin and endothelin signaling in ovarian cancer cells: Epigenetic regulation of gene transcription (2010) (0)
Partial amino acid sequence of the V region of a kappa-type Bence Jones cryoprotein. (1978) (0)
388 Positive inter-regulation between beta-catenin and endothelin signaling: critical role of beta-arrestin-1 in the epigenetic regulation of gene transcription in ovarian cancer cells (2010) (0)
Retrovirus-derived shuttle vectors in the generation of murine bispecific MoAbs to be used in ex vivo and in vivo immunotherapy. (1991) (0)
Short Communication Endothelin Receptor Blockade Inhibits Proliferation of Kaposi’s Sarcoma Cells (2001) (0)
Antigen detected by a monoclonal antibody (345.123s) Produced against human melanoma cells. (1982) (0)
Abstract 5143: ABCG2 is involved in self renewal of melanoma cancer/initiating cells and major tumor associated antigens are expressed by ABCG2-positive cells (2010) (0)
Gadolinium labeled antibodies as specific contrast agents in MRI (1989) (0)
Expression of c-kit Receptor in Normal and Transformed Human Nonlymphoid Tissues1 (2006) (0)
Methylation state of the human HLA-DR alpha gene in transgenic mice. (1991) (0)
Characterisation and protel ity of monoclonal antibodies elicited in mice tive capal against protein epitopes of antibiotic-exposed Escherichia coli (1997) (0)
Methylation state of the human HLA-DRa gene in transgenic mice (2004) (0)
Three specific CTL clones lyse melanoma cells in presence of bispecific monoclonal antibody (bsmAb) CBT3xEp2 (1991) (0)
Binding of nuclear factors to the IFN-gamma consensus sequence of the human HLA-DR alpha gene: effects of IFN-gamma on tumor cell lines. (1990) (0)
A rapid method for obtaining specific antibodies to mouse α1-fetoprotein (1982) (0)
MONOCLONAL ANTIBODY DEFINED MARKERS OF HUMAN MELANOMA CELLS (1987) (0)
474 Phosphatidylcholine-specific phospholipase c as a new molecular target to weaken the effects of her2 amplification in breast carcinoma (2010) (0)
Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model (2023) (0)
Human Ia-like antigens (Analysis of the tissue distribution and immunochemical profile with monoclonal antibodies). (1981) (0)
168 POSTER Endothelin A receptor/beta-arrestin signaling is critical for ovarian cancer metastasis: novel molecular therapeutic applications (2008) (0)
Enhancement of vaccine-mediated antitumor immunity in melanoma patients by dacarbazine treatment (2006) (0)
Prognostic relevance of LGALS3BP in human colorectal carcinoma (2015) (0)
Isolation and characterization of cytotoxic T lymphocytes (CTL) clones derived from a patient with breast carcinoma (1991) (0)
Membrane bound and cytoplasmic human melanoma associated antigens molecular and serological characterization with mono clonal antibodies (1981) (0)
Molecular approach to the nucleo-melanosomal interaction in human melanoma cells (2004) (0)
An immunohistochemical analysis of the monoclonal antibody MM1.80 recognizing a novel breast tumor associated antigen (1986) (0)
A rapid method for obtaining specific antibodies to mouse alpha 1-fetoprotein. (1982) (0)
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation (2021) (0)
Development of the whole tomato and olive-based food supplement enriched with anti-platelet aggregating nutrients (2022) (0)
Abstract 2551: Acquisition of epithelial-mesenchymal transition phenotype of chemoresistant ovarian cancer cells is linked with activation of the endothelin signaling pathway (2010) (0)
Multiply drug-resistant human CCRF-CEM T-lymphoblastoid cells have decreased amount of a 90 KDa cell surface protein. (1989) (0)
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling. (2011) (0)
Contents, Supplement 1, 1984 (1984) (0)
134 Epigenetic immunomodulation by SGI-110 combined with immune checkpoint blockade for new therapeutic strategies (2014) (0)
Effect of Recombinant Human Leukocyte , Fibroblast , and Immune Interferons on Expression of Class I and II Major Histocompatibility Complex and Invariant Chain in Early Passage Human Melanoma Cells 1 (2006) (0)
Identification of tumor progression (TP) associated molecules in malignant melanoma using the hybridoma technology: 63 (1993) (0)
Monoclonal antibody treatments on 3ll variants with different metastatic capacity (1986) (0)
Human developing metanephric nephrons. Morphological, immunohistochemical and histochemical studies. (1989) (0)
Molecular subtypes of breast cancer and cyclooxygenase-2 overexpression: Predictive role in patients treated with adjuvant anthracycline-based chemotherapy (2008) (0)
Combination of immunotherapy with chemotherapy to redirect the antitumor immune response: from preclinical studies to patients (2008) (0)
[Methods for the determination of soluble immune complexes. (125 I-Clq binding test)]. (1977) (0)
548 Positive inter-regulation between beta-catenin and endothelin signaling in ovarian cancer cells: epigenetic regulation of ET-1 gene expression (2010) (0)
Constitutive and induced expression of hla dr antigens (1985) (0)
Abstract 5437: Dual targeting of ErbB-2 and ErbB-3: A new potential strategy for the treatment of pancreatic cancer (2014) (0)
Abstract 707: Acquisition of chemoresistance and epithelial to mesenchymal phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells (2011) (0)
An immunoenzymatic assay of tumor-specific antigen. Abstr. (1975) (0)
558 POSTER Epithelial mesenchymal transition (EMT) and hMena expression as determinants of sensitivity of pancreatic adenocarcinoma (PDAC) cell lines to EGFR tyrosine kinase Inhibitors (TKI) (2006) (0)
Abstract C58: Humanization and characterization of an anti-ErbB-3 murine monoclonal antibody. (2011) (0)
Human Histocompatibility Antigens in Malignant Tumors of Nonlymphoid Origin (1984) (0)
45th Annual Meeting of the Italian Cancer Society Bergamo, 9-12 November 2003 (2004) (0)
Abstract 1286: Endothelin-1-induced angiogenesis is regulated by PHD2 in a HIF-1α-dependent manner (2010) (0)
[Skin cancer risk factors in childhood: findings of a survey in an Italian area characterized by atypical migration]. (2009) (0)
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes (2019) (0)
Effect of Recombinant Human Leukocyte, Fibroblast, and Immune Interferons on Expression of Class I and II Major Histocompatibility Complex and Invariant Chain in Early Passage Human Melanoma Cells1 (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Pier Giorgio Natali?

Pier Giorgio Natali is affiliated with the following schools:

Pier Giorgio Natali's Academic­Influence.com Rankings

Pier Giorgio Natali's Degrees

Similar Degrees You Can Earn

Why Is Pier Giorgio Natali Influential?

Pier Giorgio Natali's Published Works

Published Works

What Schools Are Affiliated With Pier Giorgio Natali?

Pier Giorgio Natali's AcademicInfluence.com Rankings